Does Direct-to-Consumer Advertising of Antidepressants Lead to a Net Social Benefit?

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.26, Iss.7, 2008-01, pp. : 557-566

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct-to-Consumer Advertising of Prescription Drugs: Does it Add to the Overuse and Inappropriate Use of Prescription Drugs or Alleviate Underuse?

By Donohue Julie M.

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 1, 2006-01 ,pp. : 17-24

Adis International

Access to resources Recommend Favorite

Value-Based Pricing: Incentive for Innovation or Zero Net Benefit?

By Hughes Dyfrig A.

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 731-735

Adis International

Access to resources Recommend Favorite

On-treatment apolipoprotein levels: predictive benefit?

Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Can tumour response predict a survival benefit?

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Aspirin dosage critical to clinical benefit?

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite